The identification of Human herpesvirus 6B (HHV-6B) epitopes that are recognized by T-cells could contribute to the development of potential vaccines and immunotherapies. Here, we identified CD4 and H-2K-restricted CD8 T-cell epitopes on the glycoprotein Q1 of HHV-6B (BgQ1), which is a unique glycoprotein and essential for HHV-6B viral entry, by using in vivo electroporation with a plasmid DNA encoding BgQ1, overlapping peptides spanning the BgQ1 sequence, ELISPOT assay for quantification of gamma interferon (IFN-γ), and computer-based T-cell epitope prediction programs. The CD4 and CD8 T-cell epitopes identified in BALB/c mice in this study could be a good animal model system for use in the development of T-cell responses, inducing HHV-6B vaccines or immunotherapies.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6405833PMC
http://dx.doi.org/10.1038/s41598-019-40372-5DOI Listing

Publication Analysis

Top Keywords

cd4 h-2k-restricted
8
human herpesvirus
8
vaccines immunotherapies
8
cd8 t-cell
8
t-cell epitopes
8
identification cd4
4
h-2k-restricted cytotoxic
4
cytotoxic lymphocyte
4
epitopes
4
lymphocyte epitopes
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!